Adaptive Biotechnologies Corp. (ADPT)
15.42
-0.32
(-2.00%)
USD |
NASDAQ |
Dec 11, 16:00
15.42
0.00 (0.00%)
After-Hours: 16:27
Adaptive Biotechnologies Market Cap: 2.355B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Akero Therapeutics, Inc. | 4.499B |
| Ionis Pharmaceuticals, Inc. | 12.81B |
| Regeneron Pharmaceuticals, Inc. | 78.49B |
| Vertex Pharmaceuticals, Inc. | 113.16B |
| Ultragenyx Pharmaceutical, Inc. | 3.492B |
Market Cap Related Metrics
| PS Ratio | 9.339 |
| Price to Book Value | 11.52 |
| Price | 15.42 |
| Earnings Yield | -3.49% |